ANXA1 and central nervous system cancer: Compared with the previous studies, we revealed that ANXA1 was also upregulated in M2 macrophages derived from the glioma immune microenvironment, indicating that ANXA1 may exert pro-tumor and inhibitory immune effects in both tumors intrinsically and the tumor microenvironment.